Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 88 (8) , 649-656
Abstract
No abstract availableKeywords
Funding Information
- Jazz Pharmaceuticals (NCT02362529)
- Canadian Institutes of Health Research
- National Institutes of Health
- Canada Foundation for Innovation
- National Institute on Drug Abuse (DA04066)
- Canada Research Chairs (GSD-157948, MOP-136955)
- Azrieli Foundation
- Janssen Pharmaceutica
- Brain and Behavior Research Foundation
This publication has 43 references indexed in Scilit:
- Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled studyJournal of Affective Disorders, 2012
- Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPAJournal of Cerebral Blood Flow & Metabolism, 2012
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28Journal of Cerebral Blood Flow & Metabolism, 2011
- Quantitation of Translocator Protein Binding in Human Brain with the Novel Radioligand [18F]-FEPPA and Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 2011
- Evaluation of the PBR/TSPO Radioligand [18F]DPA-714 in a Rat Model of Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2009
- Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brainNeuropathology and Applied Neurobiology, 2009
- The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological DisordersJournal of Neuropathology & Experimental Neurology, 2008
- Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptorsNuclear Medicine and Biology, 2008
- Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinicNature Neuroscience, 2007
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960